We are live on
!
Find out more
GCM
Ghisallo Capital Management Portfolio holdings
AUM
$3.63B
1-Year Est. Return
30.51%
This Fund
S&P 500
This Quarter
Est. Return
+5.34%
1 Year Est. Return
+30.51%
3 Year Est. Return
+102.79%
5 Year Est. Return
+106.47%
10 Year Est. Return
–
AUM
$838M
AUM Growth
+$422M
(+101%)
Cap. Flow
+$414M
Cap. Flow
% of AUM
49.47%
Top 10 Holdings %
Top 10 Hldgs %
41.74%
Holding
134
New
65
Increased
4
Reduced
8
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$57.3M |
| 2 |
GE HealthCare
GEHC
|
+$39.9M |
| 3 |
PG&E
PCG
|
+$33.9M |
| 4 |
RenaissanceRe
RNR
|
+$29.8M |
| 5 |
Agilon Health
AGL
|
+$22.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$26.6M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$15.7M |
| 3 |
CVII
Churchill Capital Corp VII Class A Common Stock
CVII
|
+$9.84M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.36M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$7.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.54% |
| 2 | Technology | 15.57% |
| 3 | Consumer Discretionary | 14.85% |
| 4 | Industrials | 10.26% |
| 5 | Financials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Alphatec Holdings
ATEC
$1.46B
| $1.8M | 0.21% |
+100,000
| New | +$1.56M |
|
77
Bloom Energy
BE
$63.7B
| $1.64M | 0.2% |
100,000
| – | – |
|
78
iShares Silver Trust
SLV
$31.3B
| $1.61M | 0.19% |
77,000
-80,500
| -51% | -$1.79M |
|
79
Southwest Gas
SWX
$6.59B
| $1.59M | 0.19% |
25,000
| – | – |
|
|
HSAI
80
Hesai Group
HSAI
$3.01B
| $1.58M | 0.19% |
150,000
| – | – |
|
81
Terreno Realty
TRNO
$7.42B
| $1.5M | 0.18% |
25,000
| – | – |
|
|
SLRN
82
DELISTED
ACELYRIN
SLRN
| $1.46M | 0.17% |
+70,000
| New | +$1.43M |
|
|
SBDS
83
DELISTED
Solo Brands Inc
SBDS
| $1.42M | 0.17% |
+6,250
| New | +$1.55M |
|
84
Protagonist Therapeutics
PTGX
$9.66B
| $1.38M | 0.16% |
+50,000
| New | +$1.25M |
|
85
ATS Corp
ATS
$1.96B
| $1.24M | 0.15% |
+26,869
| New | +$1.21M |
|
86
Kura Sushi USA
KRUS
$586M
| $1.16M | 0.14% |
+12,500
| New | +$923K |
|
87
Kymera Therapeutics
KYMR
$8.91B
| $1.15M | 0.14% |
+50,000
| New | +$1.43M |
|
88
Lexicon Pharmaceuticals
LXRX
$1.08B
| $1.15M | 0.14% |
+500,000
| New | +$1.33M |
|
89
Verastem
VSTM
$603M
| $1.12M | 0.13% |
+150,000
| New | +$1.04M |
|
90
Kimbell Royalty Partners
KRP
$1.48B
| $1.1M | 0.13% |
75,000
| – | – |
|
|
ZING
91
DELISTED
FTAC Zeus Acquisition Corp. Class A Common Stock
ZING
| $1.08M | 0.13% |
103,550
-71,450
| -41% | -$739K |
|
92
Cactus
WHD
$5.61B
| $1.06M | 0.13% |
25,000
| – | – |
|
|
CVAC
93
DELISTED
CureVac
CVAC
| $1.04M | 0.12% |
100,000
| – | – |
|
|
KLRS
94
Kalaris Therapeutics
KLRS
$96.4M
| $994K | 0.12% |
+12,709
| New | +$1.21M |
|
95
CorMedix
CRMD
$577M
| $991K | 0.12% |
+250,000
| New | +$1.24M |
|
96
EverCommerce
EVCM
$1.89B
| $888K | 0.11% |
75,000
| – | – |
|
97
Disc Medicine
IRON
$2.98B
| $888K | 0.11% |
+20,000
| New | +$710K |
|
98
IDEAYA Biosciences
IDYA
$3.58B
| $881K | 0.11% |
+37,500
| New | +$771K |
|
99
Atour Lifestyle Holdings
ATAT
$4.84B
| $812K | 0.1% |
+50,000
| New | +$972K |
|
100
Driven Brands
DRVN
$2.1B
| $677K | 0.08% |
25,000
| – | – |
|
Similar funds
VI
ACM
SCM
OCM
SL
AA
GCM
MTIM
Ghisallo Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Ghisallo Capital Management held 134 positions worth $838M, up 101% from $416M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Ghisallo Capital Management deployed $414M of net new capital in Q2 2023, opening 65 new positions and adding to 4 existing holdings. Its largest new stake was Kenvue: 2,200,000 shares worth $58.1M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $26.6M trimmed.
- Ghisallo Capital Management's largest Q2 2023 buy was Kenvue: 2,200,000 shares worth $58.1M.
- Ghisallo Capital Management added most to Nextpower Inc in Q2 2023, an estimated $15.7M increase.
- Ghisallo Capital Management's biggest Q2 2023 reduction was Johnson & Johnson, cutting an estimated $26.6M.
- Ghisallo Capital Management fully exited Charles Schwab in Q2 2023, selling an estimated $15.7M.
- Ghisallo Capital Management's ten largest holdings make up 42% of its $838M portfolio in Q2 2023.
- Ghisallo Capital Management opened 65 new positions and closed 15 in Q2 2023.
- Ghisallo Capital Management's portfolio value rose 101% quarter-over-quarter to $838M.
Based on Ghisallo Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.